Business Context and Reporting Period
Company: Teleflex Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 2001
Business Overview: Teleflex operates in three primary segments: Commercial (marine, industrial, automotive), Medical (hospital supply, surgical devices), and Aerospace (cargo systems, repair services, gas turbine services).
Key Financial Metrics
| Metric (in thousands) | Q3 2001 | Q3 2000 | 9 Months 2001 | 9 Months 2000 |
|---|---|---|---|---|
| Revenues | $466,014 | $420,405 | $1,439,752 | $1,313,548 |
| Net Income | $22,102 | $21,722 | $83,144 | $77,860 |
| Diluted EPS | $0.56 | $0.56 | $2.12 | $2.02 |
| Operating Profit | $44,335 | $41,362 | $157,219 | $144,309 |
| Gross Margin | 27.6% | 27.2% | N/A | N/A |
| Operating Margin | 9.5% | 9.8% | N/A | N/A |
| Cash Flow from Operations (9mo) | $109,514 (vs $135,531 prior year) | |||
| Total Borrowings | $480,200 (Sep 30, 2001) vs $338,600 (Dec 31, 2000) | |||
| Cash and Equivalents | $44,581 (Sep 30, 2001) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 11% in Q3 2001 and 10% for the nine-month period, driven by acquisitions in the Commercial and Aerospace segments and core growth in Aerospace.
- Segment Performance:
- Commercial: Sales up 12% due to acquisitions (Morse Controls, fluid handling systems), offset by declines in Automotive sales due to weaker North American vehicle production.
- Medical: Sales flat year-over-year; operating profit up 8% due to improved product mix and efficiencies.
- Aerospace: Sales up 18% and operating profit up 17%, driven by cargo systems and repair services, despite declines in manufactured components.
- Profitability: Gross margin improved to 27.6% from 27.2%. Operating margin declined slightly to 9.5% from 9.8% due to increased operating expenses in Commercial and Aerospace segments.
- Debt Levels: Total borrowings increased significantly to $480.2 million from $338.6 million at year-end 2000, primarily to finance the Morse Controls acquisition. The debt-to-capitalization ratio rose to 39% from 33%.
- Cash Flow: Operating cash flow for the nine months decreased to $109.5 million from $135.5 million, largely due to increased working capital requirements and timing of payments.
Guidance, Outlook, and Risks
- Accounting Changes: The company adopted SFAS 133 (Derivatives) in 2001, resulting in a net $2.0 million charge to equity. The company is analyzing the impact of SFAS 142 (Goodwill), which will cease annual amortization of goodwill (estimated at $15 million annually) starting in 2002, replacing it with impairment testing.
- Forward-Looking Statements: Management notes that future results depend on assumptions subject to risks and uncertainties, including market conditions and currency fluctuations.
- Foreign Currency: The company utilizes forward contracts to hedge exposure to the Euro, British pound, and Canadian dollar. Medical sales were impacted by weaker currencies in the prior year.
- Dividends: Dividends per share increased to $0.170 in Q3 2001 from $0.150 in Q3 2000.
Key Facts for Investor Verification
- Acquisition Impact: Verify the integration progress and financial contribution of the Morse Controls acquisition and other recent purchases in the Commercial and Aerospace segments.
- Debt Servicing: Monitor the impact of the increased debt load ($480.2 million) on interest expenses and future liquidity, given the rise in the debt-to-capitalization ratio.
- Automotive Exposure: Assess the sensitivity of the Commercial segment's performance to North American vehicle production trends, which caused a decline in that product line.
- Working Capital Trends: Review the continued pressure on operating cash flow caused by increases in accounts receivable and inventory levels.
- Accounting Transition: Confirm the final impact of SFAS 142 on future earnings once goodwill amortization ceases in 2002.